DentalCare Logo

Post-Pandemic Dental Practice: COVID-19, Oral Health & Infection Control

Course Number: 665

PDF

References/Additional Resources

  1. Zhu N, Zhang D, Wang W, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–733. doi:10.1056/NEJMoa2001017.

  2. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern [published correction appears in Lancet. 2020 Jan 29;:]. Lancet. 2020;395(10223):470–473. doi:10.1016/S0140-6736(20)30185-9.

  3. Liu T, Hu J, et al. Transmission Dynamics of 2019 Novel Coronavirus (2019-nCoV). The Lancet. 2020 Feb 05. Available at SSRN: doi:10.2139/ssrn.3526307. Accessed December 12, 2023.

  4. COVID Data Tracker. Centers for Disease Control and Prevention. Accessed December 12, 2023.

  5. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China [published correction appears in Lancet. 2020 Jan 30;:]. Lancet. 2020;395(10223):497–506. doi:10.1016/S0140-6736(20)30183-5.

  6. Guan WJ, Ni ZY, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China [published online ahead of print, 2020 Feb 28]. N Engl J Med. 2020;NEJMoa2002032. doi:10.1056/NEJMoa2002032.

  7. Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China [published online ahead of print, 2020 Feb 7]. JAMA. 2020;e201585. doi:10.1001/jama.2020.1585.

  8. SeyedAlinaghi S, Mirzapour P, Dadras O, et al. Characterization of SARS-CoV-2 different variant and related morbidity and mortality: a systematic review. Eur J Med Res 2021; 26; 51.

  9. Lu CW, Liu XF, Jia ZF. 2019-nCoV transmission through the ocular surface must not be ignored. Lancet. 2020;395(10224):e39. doi:10.1016/S0140-6736(20)30313-5.

  10. Rothe C, Schunk M, Sothmann P, et al. Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany. N Engl J Med. 2020;382(10):970–971. doi:10.1056/NEJMc2001468.

  11. Kirubananthan L, Illuri R, Rajendran R, Chandrasekaran PR. Mechanism and transmission routes of COVID-19. Environmental and Health Management of Novel Coronavirus Disease (COVID-19). 2021; 65-88.

  12. U.S. Department of Labor, Occupational Safety and Health Administration. 29 CFR Part 1910.1030: Occupational exposure to bloodborne pathogens—OSHA, final rule. Fed Regist. 1991;56:64004–64182. Accessed December 12, 2023

  13. Garner, JS, The Hospital Infection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals (published correction appears in Infect Control Hosp Epidemiol 1996;17[4]:214). Infect Control Hosp Epidemiol. 1996; 17: 53–80

  14. Siegel, JD, Rhinehart, E, Jackson, M, Chiarello, L, Health Care Infection Control Practices Advisory Committee. 2007 Guideline for isolation precautions: preventing transmission of infectious agents in health care settings. Am J Infect Control. 2007; 35: S65–S164. Accessed December 12, 2023

  15. Harte, JA. Standard and Transmission-Based Precautions J Am Dent Assoc 2010; 141(5): 572 – 581.

  16. Centers for Disease Control and Prevention. Coronavirus Disease 2019 (COVID-19). Potential Exposures at Work. Accessed December 12, 2023

  17. Centers for Disease Prevention & Control. Infection Control and Prevention in Dental Settings. Summary of Infection Prevention Practices in Dental Settings. Accessed December 12, 2023

  18. To KK, Tsang OT, Chik-Yan Yip C, et al. Consistent detection of 2019 novel coronavirus in saliva [published online ahead of print, 2020 Feb 12]. Clin Infect Dis. 2020;ciaa149. doi:10.1093/cid/ciaa149.

  19. Rodríguez-Morales AJ, MacGregor K, Kanagarajah S, Patel D, Schlagenhauf P. Going global - Travel and the 2019 novel coronavirus. Travel Med Infect Dis. 2020;33:101578. doi:10.1016/j.tmaid.2020.101578.

  20. Faecher RS, Thomas JE, Bender BS. Tuberculosis: a growing concern for dentistry?. J Am Dent Assoc. 1993;124(1):94–104. doi:10.14219/jada.archive.1993.0003.

  21. Nash KD. How infection control procedures are affecting dental practice today. J Am Dent Assoc. 1992;123(3):67–73. doi:10.14219/jada.archive.1992.0076.

  22. Patel M. Infection control in dentistry during COVID-19 pandemic: what has changed? Heliyon 2020 e05402. doi:10.1016/j.heliyon.2020.e05402

  23. Benzian H, Beltran-Aguilar E, Niederman R. Systemic management of pandemic risks in dental practice: A consolidated framework for COVID-19 control in dentistry. Frontiers in Medicine. 2021; 8: 644515.

  24. Hamedani S, Farshidfar N, Ziaei A, Pakravan H. The dilemma of COVID-19 in dental practice concerning the role of saliva in transmission: a brief review of current evidence. Eur Oral Res 2020; 54: 92-100.

  25. Gallagher JE, Johnson I, Verbeek JH. Clarkson JE, Innes N. Relevance and paucity of evidence: a dental perspective on personal protective equipment during the COVID-19 pandemic. Br Dent J 2020; 229: 121-124.

  26. Beltran-Aguilar E, Benzian H, Niederman R. Rational perspectives on risk and certainty for dentistry during the COVID-19 pandemic. Am J Infect Control 2021; 49: 131-133.

  27. COVID-19 Dental Services Evidence Review (CoDER) Working Group. Recommendations for the Re-Opening of Dental Services: A Rapid Review of International Sources (Version 1.3). Accessed April 25, 2023

  28. Ferretti L. Weymant C. Kendall M, et al. Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing. Science 2020; https:doi.org/10.1126/science.abb6936. Accessed December 12, 2023

  29. Centers for Disease Control and Prevention. Infection Control Guidance. Accessed December 12, 2023

  30. Baghizadeh FM. What dentists need to know about COVID-19. Oral Oncol 2020; 105: 104741.

  31. United States Department of Labor. Occupational Safety and Health Administration. Dentistry Workers and Employers. Accessed December 12, 2023

  32. Cheng HC, Chang YJ, Liao SR, Siewchaisakul P, Chem SLS. The impact of COVID-19 on knowledge, attitude, and infection control behaviors among dentists. BMC Oral Health 2021; 21: 584.

  33. Estrich C, Mikkelsen M, Morrissey R, Geisinger ML, Ioannidou E, Vujicic M, Araujo MWB. Estimating COVID-19 prevalence and infection control practices among US Dentists. J Am Dent Assoc 2020; 151(11): 815-824.

  34. Araujo MWB, Estrich CG, Mikkelsen M, Morrisey R, Harrison B, Geisinger ML, Ioannidou E, Vujicic M. COVID-19 among dentists in the United States: A 6-month longitudinal report of accumulative prevalence and incidence. J Am Dent Assoc 2021; 152(6): 425-433.

  35. Centers for Disease Control and Prevention (CDC). Summary of Infection Prevention Practices in Dental Settings: Basic Expectations for Safe Care. Atlanta: CDC, US Department of Health and Human Services. 2016.

  36. Centers for Disease Control and Prevention (CDC). Guidance for Dental Settings: Interim Infection Prevention and Control Guidance for Dental Settings During the COVID-19 Response. 2020. Accessed December 12, 2023

  37. American Dental Association (ADA) What Constitutes a Dental Emergency? 2020. Accessed April 25, 2023

  38. EPA. Pesticide Registration. List N: Disinfectants for Use Against SARS-CoV-2. Accessed December 12, 2023

  39. Coronavirus Disease 2019 (COVID-19) | CDC. Accessed December 12, 2023

  40. Ghai S. Teledentistry during COVID-19 pandemic. Diabetes Metab Syndr 2020; 14(5): 933-935.

  41. Bahanan L, Alsharif M. Factors affecting the acceptance of teledentistry determined using the technology acceptance model: A cross-sectional study. Digit Health 2023; 9: 20552076231158034.

  42. United States Department of Labor. Occupational Safety and Health Administration. Dentistry Workers and Employers. Accessed December 12, 2023

  43. Seirafianpour F, Sodgar S, Pour Mohammad A, et al. Cutaneous manifestations and considerations in COVID-19 pandemic: a systematic review. Dermatol Ther 2020; e13986.

  44. Mitchell MB, Workman AD, Rathi VK, Bhattacharyya N. Smell and taste loss associated with COVID-19 infection. Laryngoscope 2023; 133(9): 2357-2361.

  45. Iranmanesh B, Khalili M, Amiri R, Zartab H, Aflatoonian M. Oral manifestations of COVID-19 disease: A review article. Dermatol Ther 2021; 34(1): e14578.

  46. Farid H, Khan M, Jamal S, Ghafoor R. Oral manifestations of Covid-19-A literature review. Rev Med Virol 2022; 32(1): e2248.

  47. Soares CD, Souza LL, de Carvalho MGF, Pontes HAR, Mosqueda-Taylor A, Hernandez-Guerrero JC, do Nascimento Medeiros SD, de Oliveira Sales A, Alves FA, Lopes Pinto CA, de Almeida OP. Oral Manifestations of Coronavirus Disease 2019 (COVID-19): A Comprehensive Clinicopathologic and Immunohistochemical Study. Am J Surg Pathol 2022; 46(4): 528-536.

  48. Aragoneses J, Suarez A, Algar J, Rodriguez C, Lopez-Valverde N, Aragonese JM. Oral manifestations of COVID-19: Updated systematic review with meta-analysis. Front Med 2021; 8: e726753.

  49. Rocha BA, Souto GR, de Mattos Camargo Grossman S, et al., Viral enanthema in oral mucosa: a possible diagnostic challenge in the COVID-19 pandemic. Oral Dis 2020.

  50. Reis VP, Bezerra AR, Maia ABP, Marques LC, Conde DC. An integrative review of oral manifestations in patients with COVID-19: signs directly related to SARS-CoV-2 infection or secondary findings? Int J Dermatol. 2022; 61(3): 278-290.

  51. Kornman KS. Mapping the pathogenesis of periodontitis: A new look. J Periodontol 2008; 79(85): 1560-1568.

  52. Nesse W, Abbas F, van der Ploeg I, Spijkervet FKL, Dijkstra PU, Vissink A. Periodontal inflamed surface area: quantifying inflammatory burden. J Clin Periodontol 2008; 35(80): 668-673.

  53. Noack B, Genco RJ, Trevisan M, Grossi S, Zambon JJ, De Nardin E. Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol 2001; 72(9): 1221-1227.

  54. Li T, Lu H, Zhang W. Clinical observation and management of COVID-19 patients. Emerg Microbes Infect 2020; 9(1): 687-690.

  55. Chen W, Lan Y, Yuan X, et al. Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity. Emerg Microbes Infect 2020 9(1): 386-389.

  56. Wang X, Fang X, Cia Z, et al. Comorbid chronic diseases and acute organ injuries are strongly correlated with disease severity and mortality among COVID-19 patients. Research (Wash DC) 2020; 2020: 2402961.

  57. Mulchandai R, Lyngdoh T, Kakkar AK, et al. Deciphering the COVID-19 cytokine storm. Eur J Clin Invest 2021; 51(1): e13429.

  58. Hamit ZN. A systematic review of systematic reviews on the COVID-19 pandemic. SN Compr Clin Med 2021; 180(9): 419-436.

  59. Rajpal A, Rahimi L, Ismail-Belgi F. Factors leading to high morbidity and mortality of COVID-19 in patients with type 2 diabetes. J Diabetes 2020; 12(12): 895-908.

  60. Bao L, Zhang C, Dong J, et al. Oral microbiome and SARS-CoV-2; beware of lung co-infection. Front Microbiol 2020; 11:1840.

  61. Elisetti N. Periodontal pocket and COVID-19: could there be a possible link? Med Hypotheses 2021; 146: 110355.

  62. Genco RJ, Borgnakke WS. Risk factors for periodontal disease. Periodontol 2000 2013; 62: 59-94.

  63. Gupta S, Hayek SS, Wang W, et al. Factors associated with death in critically ill patients with coronavirus disease 2019 in the US J Am Med Assoc Inter Med 2020; 180: 1436-1447.

  64. Tamimi F, Altigani S, Sanz M. Periodontitis and coronavirus disease 2019. Periodontol 2000 2022; 89: 207-214.

  65. Schenkein HA, Papapanou PN, Genco R, et al. Mechanisms underlying the association between periodontitis and atherosclerotic disease. Periodontol 2000 2020; 83(1): 90-106.

  66. Kara C, Celen K, Dede FO, et al. Is periodontal disease a risk factor for developing severe COVID-19 infection? The potential role of Galectin-3 Exp Biol Med 2020; 245(16): 1425-1427.

  67. Marouf N, Cai W, Said KN, et al. Association between periodontitis and severity of COVID-19 infection. J Clin Periodontol 2021; 48(4): 483-491.

  68. Sirin DA, Ozcelik F. The relationship between COVID-19 and the dental damage stage determined by radiological examination. Oral Radiol 2021; 3: 1.

  69. Fernandex Matuch B, Dolhnikoff M, Maia GVA, et al. Periodontal tissues are targets for SARS-CoV-2: a post-mortem study. J Orla Microbiol 2020: 13(1): 1848135.

  70. Basso L, Chacun D, Sy K, Gorsgogeat B, Gritsch K. Peirodontal diseases and COVID-19: a scoping review. Eur J Dent 2021; 15(4): 768-775.

  71. Gupta S, Mohindra R, Chauhan PK, et al. SARS-CoV-2 Detection in Gingival Crevicular Fluid. Journal of Dental Research. 2021;100(2):187-193.

  72. Roganovic JR. MicroRNA-146a and -155, upregulated by periodontitis and type 2 diabetes in oral fluids, are predicted to regulate SARS-CoV-2 oral receptor genes. J Periodontol 2021; 92(7): 35-43.

  73. Tonetti MS, Jepsen S, Jin L, et al. Impact of the global burden of periodontal disease on health, nutrition, and wellbeing of mankind: a call for global action. J Clin Periodontol 2017; 44(5): 456-462.

  74. Sanz M, Del Castillo AM, Jepsen S, et al. Periodontitis and cardiovascular diseases. Consensus report. Glob Heart 2020; 15(1): 1.

  75. Fine N, Chadwick JW, Sun C, et al. Periodontal inflammation primes the systemic innate immune response. J Dent Res 2021; 100(3): 318-325.

  76. Liu F, Li L, Xu M, et al. Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19. J Clin Virol 2020; 127: 104370.

  77. Mehta P, McAuley DF, Brown M, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 2020; 395: 1033-1034.

  78. Kazancioglu S, Yilmaz FM, Bastug A, et al. Assessment of galectin-1, galectin-3, and PGE2 levels in patients with COVID-19 Jpn J Infect Dis 2021; 74(6): 530-536.

  79. Masso-Silva JA, Moshensky A, Lam MTY, et al. Increased peripheral blood neutrophil activation phenotypes and neutrophil extracellular trap formation in critically ill coronavirus disease 2019 (COVID-19) patients: a case series and review of the literature. Clinical Infectious Diseases 2022 74(3): 479-489.

  80. Sampson V, Kamona N, Sampson A, et al. Could there be a link between oral hygiene and the severity of SARS-CoV-2 infections? Br Dent J 2020; 228(12): 971-978.

  81. Xu H, Zhong L, Deng J, et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int J Oral Sci 2020; 12(1): 8.

  82. Botros N, Iyer P, Ojcius DM. Is there an association between oral health and severity of COVID-19 complications? Biomed J 2020; 43(4): 325-327.

  83. Awano S, Ansai T, Takata Y, et al. Oral health and mortality risk from pneumonia in the elderly. J Dent Res 2008; 87(4): 334-339.

  84. Aquino-Martinez R, Hernandez-Vigueras S. Severe COVID-19 lung infection in older people and periodontitis. J Clin Med 2021; 10(2): 279.

  85. Pfutzner A, Lazzara M, Jantz J, et al. Why do people with diabetes have a high risk for severe COVID-19 disease?—A dental hypothesis and possible prevention strategy. J Diabetes Sci Technol 2020; 14(4): 769-771.

  86. Chapple ILC, Mealey BL, Van Dyke TE, et al. Periodontal health and gingival diseases and conditions on an intact and a reduced periodontium: Consensus report of workgroup 1 of the 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases and Conditions. J Periodontol. 2018; 89(Suppl 1): S74-S84.

  87. Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Primers 2017; 3: 17038.

  88. Nazir MA. Prevalence of periodontal disease, its association with systemic disease and prevention. Int J Health Sci (Qassim) 2107; 11(2): 72-80.

  89. Yang LC, Suen YJ, Wang YH, et al. The association of periodontal treatment and decreased pneumonia. Int J Environ Res Public Health 2020; 17(1): 356.

  90. Mehta V, Goel S, Kabarriti R, et al. Case fatality rate of cancer patients with COVID-19 in an New York hospital system. Cancer Discov 2020; 10(7): 935-941.

  91. Caballero AE, Ceriello A, Misra A, et al. COVID-19 in people living with diabetes: an international consensus. J Diabetes Complications 2020; 34(9): 107671.

  92. Scannapieco FA, Ho AW. Potential associations between chronic respiratory disease and periodontal disease: analysis of National Health and Nutrition Examination Survey III. J Periodontol 2001; 72(1): 50-56.

  93. Grigoriadis A, Raisanen IT, Parnanen P, Tervahartiala T, Sorsa T. Is there a link between COVID-19 and periodontal disease? A narrative review. Eur J Dent 2022; 16(3): 514-520.

  94. Baima G, Marruganti C, Sanz M, Aimetti M, Romandini M. Periodontitis and COVID-19: Biologic Mechanisms and Meta-analysis of epidemiologic evidence. J Dent Res 2022; 10(12) 1430-1440.

  95. Centers for Disease Control and Prevention. HPV and Oropharyngeal Cancer. Accessed December 12, 2023

  96. Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med 2021. 27(4):601-615.

  97. Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. medRxiv 2020; 2.020.2012.2014.20248802

  98. Hur K, Choi JS, Zheng M, Shen J, Wrobel B. Association of alterations in smell and tast with depression in older adults. Laryngoscope Invest Otolaryngol 2018; 3: 94-99.

  99. Ismail II, Gad KA. Absent blood oxygen level-dependent functional magnetic resonance imaging activation of the orbitofrontal cortex in a patient with persistent cacosmia and cacogeusia after COVID-19 infection. JAMA Neurol 2021. 8(5):609–610.

  100. Marchesan JT, Warner BM, Byrd KM. The “oral” history of COVID-19: Primary infection, salivary transmission, and post-acute implications. J Periodontol 2021; 92: 1357-1367.

Additional Resources

0/11Next